| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Tân-Tân Foods [Automatic translation follows] The healthy and nutritious plant-based alternative Tân-Tân is a startup that advocates for a healthier and more plant-based food transition, through a range of medallions rich in protein and easy to cook. vegetarian, vegan, protein, and food transition Type: | 2 | 1 | 0 | 2 |
 |  Robo Bionics A Hand for a Missing Hand with the Sense of Touch | National Startup Award 2021 | CSR Partnerships | Social Impact Robo Bionics has developed Grippy India’s Own NABL Lab Safety Tested and Certified, 3D printed Prosthetic hand with a sense of touch and multi-grip control. Designed, engineered, and proudly made in India, Grippy is a lightweight and affordable, battery-powered prosthesis now available in the Indian market for people with below elbow amputation age 15 years and above. Welcome to the future where we have made Bionics as simple as switching on a light bulb. Robo Bionics a Recognized … Type: | 6 | 0 | 6 | 5 |
 | Eurofins Discovery Eurofins Discovery offers you a complete, single-source solution for drug discovery products and services. Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, … Type: | 2 | 2 | 0 | 212 |
 | NanoSpun Technologies We harness the power of biology to create revolutionary live-active cell-based products and solutions. NanoSpun is a global pioneer and frontrunner in the biotech, advanced materials and bioprinting spaces. We are leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics. No other company can do what we do. We encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. Our current market focus is to revolutionize Skincare and Bioprocessing. … Type: | 0 | 0 | 0 | 9 |
 |  Vytrus Biotech Natural Innovation for a Better Life. Applying the real power of plants to cosmetics through biotechnology We create natural active ingredients for skincare and haircare through innovative and sustainable biotechnology processes which obtain the real power of plants. Totipotent Cells Type: | 1 | 0 | 1 | 37 |
 | Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T Type: | 2 | 1 | 2 | 20 |
 | FIRE1 Our purpose is to help millions of people living with heart failure to get their normal back. FIRE1 aims to improve patient quality of life, and patient outcomes, while lowering overall healthcare costs. Health Tech, Research & Development, Medical Devices, Software Engineering, and Clinical Type: | 2 | 2 | 0 | 62 |
 | CompagOs Transforming drug development and personalized medicine with Bon3OIDTM in vitro models CompagOs, a Swiss spin-off from ETH Zürich, is revolutionizing bone health by empowering researchers to develop breakthrough therapies and supporting doctors in matching the right patients with the right treatments. Utilizing cutting-edge 3D bioprinting technology, we create biologically relevant and reproducible organotypic human Bon3OIDTM in vitro bone models. We offer services on these models for basic research, drug efficacy, and toxicity testing, focusing on bone biology, rare bone diseases, inflammatory bone disorders, and bone oncology. 3D bioprinting, rare bone diseases, bone oncology, bone biology, drug efficacy, and drug toxicity Type: | 0 | 0 | 0 | 4 |
 | Causeway Therapeutics Healthy Ageing Through Musculoskeletal Health Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in … Type: | 2 | 0 | 1 | 6 |
 | ToxGenSolutions BV (TGS) Epigenetics-based diagnostics, prognostics and preventative therapeutics for high-impact chronic pathologies. ToxGenSolutions (TGS) applies toxicogenomic approaches on human health problems to provide the customer with epigenetic biomarker fingerprints for application in novel, more accurate, methods for the particular diagnosis of their need. TGS aims to develop novel and innovative epigenetic profiles hallmarking high-impact chronic and rare neurodevelopmental diseases to serve as early, preclinical, diagnostic verdicts of a disease. With the development of these novel tools, TGS aims to bridge the frequently large gap towards disease progression and therapeutic intervention. TGS provides novel epigenetic diagnostic methods for the early identification of pressing … Type: | 0 | 0 | 0 | 8 |
 | Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYXTM. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care and position itself to become a leader in the ophthalmic space. Ocular Therapeutix has a commercially available drug product, DEXTENZA® (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use. DEXTENZA is an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following … Type: | 1 | 0 | 0 | 285 |
 | Biotech Partners Biotech Partners is a life science recruiting company that's dedicated to solving people problems. We are Biotech Partners, one of the best d*mn life science recruitment agencies. We’re dedicated to solving people problems – it’s what we do. From biotechnology to clinical research, we take the bullsh*t out of job placement and connect real, qualified job seekers with employers in their field. Our specialty (beyond solving people problems) is all life science focused. Our search consultants have a complete understanding of what a successful hiring process will look like for you and your organization. Not only do we understand the … Type: | 0 | 0 | 0 | 8 |
 | ProteinDistillery Crafting Tomorrow's Proteins. Today! ProteinDistillery is a food-tech start-up which creates a new generation of clean and sustainable proteins for food companies using microorganisms. At ProteinDistillery we rethink a healthy and sustainable protein supply. We believe that it takes new technologies and products that enable the transition from linear to circular value chains to preserve our planet. With our innovative process we can purify proteins from residual yeast of the beer brewing process. Clean and various. Brewer’s yeast proteins are multiply applicable - from neutral-tasting foam for cappucchino to fibrous structure and spicy umami taste for meat substitutes. And all … Type: | 4 | 0 | 4 | 29 |
 | ARTCLINE GmbH Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe infections / sepsis ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the treatment of bacterial sepsis. ARTCLINE's vision is the development of innovative immune cell-based therapy approaches and to make the technology available to physicians and hospitals worldwide. The safety and effectiveness of the therapy is our top priority. Our extensive cell biological, clinical and industrial experience in the fields of immunology, sepsis diagnostics and therapy help us to … Type: | 0 | 0 | 0 | 17 |
 | AbilityPharma Ability Pharmaceuticals is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space. AbilityPharma's is currently conducting, with ABTL0812, the most advanced asset, an international multi-center, double-blind, placebo-controlled phase 2b clinical trial in patients with metastatic pancreatic cancer to investigate ABTL0812 as first-lin therapy in combination with FOLFIRINOX chemotherapy. The study includes reference centers in Spain, France, United States and Israel. ABTL0812 has finished with very positive results a phase 2a clinical trial as first-line therapy in endometrial cancer and in squamous NSCLC in combination with paclitaxel and carboplatin. The study included … Type: | 3 | 0 | 3 | 23 |
 | NLS Pharmaceutics AG Connecting Brains WE ́RE NOT CURRENTLY HIRING MISSION & VALUES To serve our patients we design affordable, safe and effective therapeutics to safeguard and empower the brain throughout all stages of life. We value partnership and Integrity, we are ethical and responsible and show respect and compassion for our patients. R&D STRATEGY The successful companies of tomorrow are those that go beyond delivering products to delivering real solutions and services. R&D is the cornerstone of our company and we promote ingenuity through an effective intellectual property policy. The advancements in science mean that more targeted, more (cost-)effective treatments are within … Type: | 0 | 0 | 0 | 9 |
 | Spectrum Medical Ltd Spectrum Medical supplies Clinical Information Solutions that include Medical Device Connectivity Technologies, Electronic Medical Record Systems, Telemedicine Capabilities and Compliance and Patient Safety Solutions. Spectrum Medical also supplies Non-invasive Diagnostics Systems for extracorporeal procedures. Type: | 0 | 0 | 0 | 263 |
 | Neupulse Improving the lives of people with Tourettes https://www.neupulse.co.uk Neupulse is the brand of Neurotherapeutics Ltd The direction of our current research was very much shaped by the feedback we received from individuals with tic disorders and their families. When we asked them for their thoughts on our research priorities we were frequently told that what was really needed was a safe and effective non-drug treatment for tic disorder that could be used outside of the clinic and gave individuals control over their tics. This led directly to us focusing on the use of peripheral nerve stimulation as a means of … Type: | 0 | 0 | 0 | 8 |
 | Spineart Quality. Innovation. Simplicity. Spineart is a privately held medical device company focused on accelerating technology adoption and elevating the standard of spinal care. As a global market leader in spine surgery, we support spine surgeons in over 60 markets worldwide and have introduced unique technologies in the field of minimally invasive surgery, motion preservation, fusion, biologics, fracture treatments, and more. Spineart offers a comprehensive portfolio of procedural solutions and technologies that combine traceable barcoded sterile-packed implants with compact instrument sets, ultimately promoting greater safety, cost-efficiency, and compliance for hospital systems worldwide. Spineart was awarded the "Prix de l'Economie Genevoise 2022" … Type: | 2 | 2 | 0 | 291 |
 | Basilea Pharmaceutica For the benefit of patients Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: … Type: | 1 | 1 | 0 | 211 |
 | Medisolutions Medical devices for professionals Type: | 5 | 1 | 4 | 5 |
 | 3P Biopharmaceuticals We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined … Type: | 4 | 1 | 2 | 258 |
 | MannKind Corporation Our mission is to give people control of their health and the freedom to live life. MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where … Type: | 4 | 0 | 3 | 562 |
 | Enzymatica AB Enzymatica is a life science company whose business concept is to offer effective aid against some of our most common diseases where viruses or bacteria play a decisive role. Over a short period the company has developed a unique oral spray for common colds, ColdZyme® and launched it on four markets. The product became the leading article for common cold in Swedish pharmacies during winter 2014-2015. For product inf, please visit at www.coldzyme.co.uk. The development program includes medical devices in upper respiratory infections and oral health, and veterinary products. Cold and Flu, Enzyme (trypsin), and Barrier technology Type: | 0 | 0 | 0 | 25 |
 | Registrar Corp Registrar Corp assists companies with U.S. FDA Regulations Registrar Corp provides U.S. FDA registration, U.S. agent, and regulatory compliance assistance for U.S. and non-U.S. companies in the food and beverage, medical device, drug, cosmetics, and radiation-emitting device industries. Registrar Corp provides expert assistance in 19 different languages, 24 hours per day, 7 days per week. Registrar Corp was founded in 2003 to assist businesses with compliance with U.S. Food and Drug Administration (U.S. FDA) regulations. Since opening its headquarters in Hampton, Virginia, USA, Registrar Corp has expanded to nineteen international offices and has aided more than 30,000 companies across 190 … Type: | 5 | 0 | 5 | 265 |
 | AURAL Alsace [Automatic translation follows] Progress 🚩and innovate🚀 Cooperate and commit to humanity HISTORICAL Created in 1972 by Professor JAHN, Head of the Nephrology and Hemodialysis Department at the Strasbourg University Hospital, AURAL is a non-profit association offering all treatment modalities for chronic renal failure as well as home hospitalization and is present throughout the Alsace region. The HAD activity began in May 2004. In 1981, AURAL started Continuous Ambulatory Peritoneal Dialysis. The first assisted AD units were set up in 1985, and in 1996, the UMs. The DPA was created in 1994, and allows young patients to continue a professional activity … Type: | 2 | 2 | 0 | 142 |
 | GMED [Automatic translation follows] GMED is a French certification body and notified body in Europe (identification number 0459). GMED is a French certification body and notified body in Europe (identification number 0459). It is responsible for assessing the conformity of medical devices according to the applicable European directives (90/385/EEC, 93/42/EEC and 98/79/EC). Accredited by the French Accreditation Committee COFRAC (under certificate No. 4-0608), in accordance with the NF EN ISO/CEI 17021: 2015 standard, GMED carries out quality management system certification activities according to ISO 9001: 2015 and ISO 13485: 2016 standards. GMED is also an audit body recognized by the MDSAP … Type: | 8 | 3 | 5 | 79 |
 | HC NEXT Expert en gestion de projet de développement de produits de santé innovants HC NEXT is a consulting company expert in project management and vendor management for drug and medical device development! HC NEXT’s mission is to speed up and derisk drugs and medical devices developments to ensure that each innovation becomes a product to patient’s benefit. HC NEXT consultants are both project management specialists and generalists in the field of healthcare product development. We kindly but seriously challenge habits, routine, bias, status quo, prejudices. Dare to be different! Type: | 3 | 1 | 3 | 3 |
 | MBCP® Technology (Advanced Medical Solutions) experts in bone regeneration Biomatlante is a specialist in synthetic biomaterials promoting bone regrowth and the precursor of bone substitute technologies. We market our products for orthopedic, trauma, spine, ENT, stomatological and dental surgery in more than 50 countries. Our Mission Develop and promote the proprietary MBCP® Technology as the scaffold of reference in any bone regeneration solution for best-in-class patient care. Our Vision Bone surgeries often demand grafts for which autograft is considered as the gold standard in terms of tissue regeneration performance and limited rejection risk. Autograft is available in limited quantity though, and harvesting methods are expensive … Type: | 3 | 1 | 3 | 30 |
 | HBR INNOVATION [Automatic translation follows] "If you take care of your employees, they will take care of your company" (R. Branson) Do you want to improve the working conditions of your employees? You have already identified, in your company, positions with physical constraints and where you encounter problems of Musculoskeletal Disorders (MSDs). Are you wondering if exoskeletons are the solution for your company/establishment? Do not hesitate to contact us at: e-mail: contact@hbrinnovation.fr Tel: 05 56 14 30 56 We will analyze the workstations together in order to find the most relevant solution for your organization. What is an exoskeleton? It is a … Type: | 1 | 1 | 0 | 1 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … Type: | 17 | 10 | 10 | 9 |
 | Hybrigenics Services Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins' functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict … Type: | 7 | 2 | 5 | 34 |
 | INSTITUT FRANCAIS D'HYPNOSE - IFH [Automatic translation follows] Professional training and research center since 1990 The French Institute of Hypnosis (IFH) is a training and research center founded in 1990 to study and train in the use of hypnosis in a therapeutic context. 🧑⚕️ For more than 30 years, we have been designing, delivering and developing hypnosis training for medical and psychotherapeutic purposes, based on the most recent scientific research and field practices, in order to contribute to improving the professional skills of practitioners. 🏥 Our training courses are available in Inter and Intra hospital. 🫶 Our values: - Humanity and ethics, at the heart … Type: | 0 | 0 | 0 | 27 |
 | IntegraGen IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of revenue in 2020. Based in France, IntegraGen is also present … Type: | 6 | 4 | 2 | 57 |
 | Protilab [Automatic translation follows] Smile creator for all Created in 2006, Protilab is the only ISO certified dental prosthesis laboratory in its sector. The work is carried out in its ultra-modern dental prosthesis laboratory certified ISO 9001:2008 and ISO 13485:2003. Protilab has, in its Parisian premises, a fully equipped laboratory allowing the realization and repair of all work in express. Protilab offers 5 quality commitments: • Certification • Materials • Traceability • Monitoring • Guarantee dental prosthesis laboratory, joint prostheses, removable prostheses, CAD/CAM, Digital impression management, and prostheses on implants Type: | 0 | 0 | 0 | 38 |
 | Pherecydes Pharma At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of … Type: | 13 | 10 | 4 | 9 |
 | Personalized Stem Cells, Inc StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients. Type: | 0 | 0 | 0 | 4 |
 | Orphazyme A/S Our vision: To profoundly impact the lives of patients with orphan diseases and their families Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our … Type: | 3 | 0 | 1 | 14 |
 | novus med Surgical innovation, knowledge and reliability novus med are a UK medical device company specialising in the provision of Medical & Surgical innovation from around the globe. We seek out technological innovation that provides solutions to patients & clinicians that delivers sustainable value and cost savings to the healthcare system. To augment this, we pride ourselves in delivering unparalleled customer support. Products include : *Complete range of Laparoscopic Reusable, Resposable and Single-instruments *EMS Thulium Fibre Laser, LaserClast35 and LaserClast20 , Laser fibres *Hugemed - Single-Use Ureteroscope, Cystoscope, Choledochoscope * Full EndoUrology Portfolio - access sheaths, baskets, dilators, stents, irrigation *Mediflex range … Type: | 0 | 0 | 0 | 9 |
 | AGECURVE LIMITED Cell Tree Analytics, somatic mutation tracking, clonal structure quantification, check out our Cell Tree Rings study here https://www.biorxiv.org/content/10.1101/2022.12.14.520419v1 mass spec proteomics, aging Type: | 1 | 0 | 0 | 1 |
 | Prostatype Genomics AB Prostatype Genomics offers prostate cancer patients a decision support for the most optimal treatment option. Prostatype Genomics offers prostate cancer patients a decision support for the most optimal treatment option! We developed a test system called 'Prostatype® Test System'. The system is based on a gene expression test, which measures the expression of three carefully selected embryonic stem cell genes in prostate cancer core needle biopsies. In conjunction with currently used clinical parameters, the PrTS predicts overall survival in relation to treatment. The Prostatype® Test System helps to choose the optimal treatment strategy for each patient. This secures quality of … Type: | 0 | 0 | 0 | 13 |
 | BOOST Pharma Treating the untreatable BOOST Pharma is based on years of collaborative research from Karolinska Institute in Stockholm with the focus on novel cell therapy treatments for Osteogenesis Imperfecta. The research teams of associate professor Cecilia Götherström and professor Magnus Westgren have shown that that treatment with BOOST Cells greatly enhanced the quality of life for patients suffering from this otherwise extremely debilitating disease. Type: | 1 | 0 | 1 | 8 |
 | ExpreS2ion Biotechnologies Innovative Vaccines for a Healthier World ExpreS2ion Biotechnologies is a clinical-stage DK based biotech company specialised in the development of new vaccines and immunotherapy products. The company has a discovery platform built around a proprietary recombinant expression system, ExpreS2 TM, developed especially for fast and efficient development and production of complex proteins required for innovative new vaccines, immunotherapy and diagnostics. The system also includes functionally modified glycosylation variants. For the clinical Phase III-stage COVID-19 vaccine, ABNCoV2, the Company employs a novel plug-&-play capsid virus-like particle (cVLP) platform, that offers competitive advantages in terms of long-term efficacy, safety, stability, and costing. … Type: | 1 | 0 | 1 | 21 |
 | LIPUM AB We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases Lipum aims for better quality of life for the millions suffering from chronic inflammatory diseases, including children. Distressed by pain, disability, and comorbidities many have to leave a normal working life in advance. We intend to increase their quality of life and decrease the considerable health care and societal costs. Inflammatory diseases, Drug development, Preclinical research, Blockbuster drugs, Chronic diseases, and Orphan drug designation Type: | 0 | 0 | 0 | 15 |
 | bit.bio The Cell Coding Company bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable … Type: | 0 | 0 | 0 | 211 |
 | LIfT BioSciences The world’s only alpha neutrophil cell therapy platform is being used to destroy all solid tumours. LIfT Biosciences is a biotech bringing to market a first-in-class alpha neutrophil cell therapy that overcomes the limitations of current therapies in solid tumours by destroying tumours both directly and indirectly. LIfT’s Immunomodulatory Alpha Neutrophils (IMANs) turn the tumour microenvironment against the tumour as they recruit the rest of the immune system to destroy the tumour to give a durable response and lasting immunity. The patented breakthrough N-LIfT platform is produced from a patented process using exceptional stem cells (iPSC or HSC), a proprietary … Type: | 1 | 0 | 1 | 22 |
 | Pheon Therapeutics Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range of hard-to-treat cancers. Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not respond to other treatments. Understanding there is no “one size fits all” in engineering ADCs, Pheon takes a methodical approach to ADC development. Using both novel and clinically validated monoclonal antibodies (mAbs) and arming them either with warheads from their proprietary payload platform which boasts a novel mechanism of action or with … Type: | 1 | 0 | 1 | 22 |
 | Laevoroc Revolutionizing treatment for leukaemia relapse. Spearheading the development of a novel PNP inhibitor poised to revolutionize treatment for leukaemia patients facing relapse post-stem cell transplantation. Oncology Type: | 0 | 0 | 0 | 3 |
 | Locate Bio Ltd Reshaping rhBMP-2 Perspectives Relieving suffering and improving quality of life with next-generation orthobiologics. Regenerative Medicine, Biomaterials, Medical devices, Drug delivery, biotechnology, BMP2, Programmed Drug Release, and Instructive Tissue Scaffolds Type: | 0 | 0 | 0 | 21 |
 | Cellbox Labs Humanizing drug development We are developing organs on a chip that are miniature organ replicas outside human body. We are focusing on microbiome and gut on on chip that allows to develop drugs more effective and study biological processes. We are also developing easy to use instrument to run experiments on the chips. Type: | 1 | 0 | 1 | 10 |
 | Nebu~Flow Transforming Respiratory Drug Delivery Nebu~Flow is developing next generation of nebulisers to unlock delivery of next generation of inhaled drugs Type: | 0 | 0 | 0 | 19 |
 | Outrun Therapeutics Unlocking the therapeutic potential of protein stabilisation Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases. Type: | 0 | 0 | 0 | 12 |
 | Accession Therapeutics Limited Developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity Type: | 1 | 1 | 0 | 44 |
 | Commit Biologics A pioneer in the activation of the complement system to treat cancer and autoimmune disease. Commit Biologics (Commit) is a pioneer in activating the complement system to kill specific target cells, with applications in cancers and autoimmune diseases. Spun out of Aarhus University, and building on more than three decades of research, Commit’s Bispecific Complement Engaging (BiCETM) platform can supercharge a conventional monoclonal antibody to activate the complement system more effectively. This is achieved by combining single domain antibodies that engage C1q, the starting point for the complement activation cascade, with an antibody that binds to a cellular target. The … Type: | 0 | 0 | 0 | 19 |
 | inven Some things cannot be comprised especially quality of life saving drugs, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That`s why, we at Inven, are committed to apply science and our resources, for providing most innovative and quality products. We strive to provide access to safe, effective and affordable medicines to the people who need them. With a strong research oriented work culture, state-of-the-art production facility and end-to-end product development capabilities - Inven is recognized as a leading, ISO 9001-2000 and WHO GMP certified, IV fluid manufacturer in the international and domestic … Type: | 2 | 1 | 0 | 33 |
 | Carezzo Nutrition bv Carezzo heeft zich gespecialiseerd in het verrijken van dagelijkse voeding met eiwit, zoals brood, cake en fruitdrinks. Carezzo Nutrition markets protein enriched food & drinks, including bread and bakery, fruit juice and soups, fruit dairy and fruit ice cream. The assortment can replace regular food, so people can increase the protein intake by 50% without eating more. This new strategy of substitution of regular food is more effective in increasing the protein intake than the current practice of suppletion with in-between snacks or medical nutrition. Carezzo Nutrition was partner in a consortium Cater with Care, and developed in close cooperation … Type: | 1 | 0 | 0 | 6 |
 | Duplaco B.V. Reliable chlorella algae producer in the EU Duplaco, based in the Netherlands, reinvented farming to grow clean and rich Chlorella microalgae in a 100% closed system, without disturbing nature. These microalgae are packed with protein, fibers, vitamins, minerals and antioxidants. Big impact, tiny footprint. Microalgae, Biotechnology, Aquaculture, Food supplements, Feed, Tailor made, Fresh, Functional ingredient, Chlorella, Algae, Vegan, and Protein Type: | 4 | 1 | 4 | 21 |
 | De Novo Foodlabs Advancing what’s next in nutrition De Novo Foodlabs is a pioneering biotech start-up revolutionising the field of nutrition. Leveraging the power of microbial fermentation, the company creates innovative products that promote better health for both people and the planet. Food design, Product Development, Recombinant proteins, nutrition, health, and alternativeproteins Type: | 1 | 1 | 1 | 13 |
 | Avant Gratify Without Sacrifice: Technology for cleaner & more sustainable marine proteins Avant is the first cultivated fish company in Asia, with operations in Singapore and Hong Kong. Thanks to Avant's technology, we will be able to have fish meat without killing fish. Our cultivated fish products are more nutritious than conventionally produced fish, GMO-free, and pollutant-free. The pilot product focus of Avant's technology platform is fish and seafood tailored for the food culture of consumers in China and Asia. biotech, cultivated meat, and alternative protein Type: | 5 | 1 | 3 | 27 |
 | Change Foods (Re)creating dairy. Animal-free.TM (Re)creating dairy. Animal-free.TM Dairy, Cheese, Alternative Protein, #animalfree, #animalfreedairy, and #animalfreecheese Type: | 8 | 2 | 6 | 20 |
 | Shiru Shiru is creating the next generation of sustainable ingredients. We're powered by Flourish, our AI discovery engine. We’re The Protein Discovery Company. Type: | 6 | 2 | 5 | 28 |
 | ReGrained Eat Up! ReGrained exists to better aligns the food we eat with the planet we love. ReGrained is the leading food upcycling technology and ingredient platform. ReGrained deploys patented technology and culinary science to rescue healthy food and craft delicious, versatile, better-for-you ingredients and products. Our flagship ingredient, ReGrained SuperGrain+R, elevates the tens of billions of pounds of de-sugared, sprouted ancient grains created annually by the brewing industry. ReGrained SuperGrain+R is a versatile, economical and environmentally friendly grain powder rich in plant protein, dietary fiber and prebiotics. Food companies around the world partner with ReGrained’s Upcycled Food Lab to power … Type: | 3 | 1 | 1 | 7 |
 | WhatIF Foods A planet-based food company founded on regenerative principles 🌍 🌱 WhatIF Foods is a forward-thinking regenerative food and beverage company with a purpose to regenerate for future generations. With a steadfast commitment to building a regenerative economy, category-by-category innovation and achieving lifetime carbon zero in the process, WhatIF Foods is changing the way we think about food and its impact on our world. Guided by the founding principles of giving back more than we take away at every step of the value chain, WhatIF Foods envisions a future where delicious plant-based foods nurture our bodies, our soils, and our partner … Type: | 1 | 1 | 0 | 20 |
 | Gainful Performance nutrition that unlocks your full potential. Performance nutrition that unlocks your full potential. We provide personalized products and 1:1 Registered Dietitian support to empower active people to reach their unique goals by transforming their health. Type: | 2 | 1 | 1 | 64 |
 | Chi Botanic We're developing the world's first synthetic biology pipeline to leverage the power of the plant cell. #IndieBio class 9 The Plant Cell Company! Type: | 0 | 0 | 0 | 1 |
 | New Culture Revolutionizing how cheese is made. The animal-free future of dairy is here—and it’s delicious. New Culture is leading the global change to an animal-free dairy future. We’re revolutionizing how cheese is made by combining traditional cheesemaking methods with modern fermentation technology. Using our groundbreaking science, any cheese is possible and can be made completely animal-free. First up is our craveable, sustainable, animal-free mozzarella that melts, stretches, bubbles, and browns to perfection. With a completely animal-free process, our cheese is free from lactose, cholesterol, hormones, and antibiotics and we cut down on water, land, energy usage by 5-10x. Not bad for … Type: | 10 | 1 | 9 | 50 |
 | myNEO Therapeutics Innovating immunotherapies, transforming tomorrow. myNEO Therapeutics is a distinguished biopharmaceutical powerhouse, dedicated to pioneer breakthrough immunotherapies to fight cancer. myNEO Therapeutics is leveraging its ImmunoEngine discovery platform to tap into novel promising tumor targets found in the dark genome – named camyotopesTM – which have the potential to unlock immunotherapy for large patient populations who currently do not respond. In parallel, the service angle of myNEO Therapeutics, myNEO Intelligence, assists biopharma companies in transforming their decision-making process from trial & error to data-driven decisions using an AI-powered platform. Deriving insights from its expansive library of clinical and molecular data, myNEO … Type: | 4 | 1 | 3 | 17 |
 | Wishbone Biotech Our goal is to revolutionize bone regeneration for dental implants by developing superior bone graft substitute products with breakthrough technology and innovative procedure. The guiding light of the genesis of Wishbone is to design and fine-tune a high-tech recipe to extract and inactivate all proteins, including prions, from bovine bone, but which would preserve the highly osteoconductive micro and nano-topography of the natural bone. Wishbone biomaterials result from the collaboration between chemists, biomedical engineers and clinician experts in dental tissue engineering. Wishbone has invested in a high tech facility for R&D, production and QC, including a qualified ISO 7 cleanroom. … Type: | 2 | 2 | 0 | 9 |
 | KiOmed Pharma Belgium biotech company providing unique pipeline of medical devices in OsteoArthritis, skin aging and ophthalmology. Capitalizing on a history of innovation and expertise in exclusive natural chitosan chemistry, KiOmed Pharma, a spinout from KitoZyme, develops a unique pipeline of medical devices that address unmet medical needs in high impact pathologies and major social burdens such as invalidating OsteoArthritis, skin aging and ophthalmology. Medical Devices & Implants, Biomaterials, Rheumatology & Joint Health, Dermatology, Biosurgery, Regenerative Medicine, Ultrapure Chitosan, and Animal-free Chitosan Type: | 1 | 1 | 0 | 46 |
 | EyeD Pharma Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts. Type: | 5 | 1 | 5 | 70 |
 | Captain T Cell Off-the-shelf T cells for solid tumor patients Captain T Cell develops first-in-class, efficacy-enhanced T cell therapies against solid tumors that are not addressed by existing treatments. Captain T Cell generates next-generation TCR-T cells with enhanced persistence and the capacity to cope with the hostile tumor microenvironment of difficult-to-treat solid tumors. In addition, the company has established a novel allogeneic platform to enable off-the-shelf treatments of solid tumors. Captain T Cell is based in Schoenefeld/Berlin, Germany, and backed by leading European investors i&i Biotech Fund I SCSp, Brandenburg Kapital GmbH, and HIL-INVENT Ges.m.b.H. Captain T Cell was founded by a dedicated … Type: | 0 | 0 | 0 | 11 |
 | PlaqueTec Ltd. Opening a new frontier in the fight against atherosclerosis PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine. CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression. A more detailed understanding of patient endotypes will … Type: | 0 | 0 | 0 | 5 |
 | SynOx Therapeutics Our mission is to focus on the unmet clinical needs of patients suffering from Tenosynovial Giant Cell Tumours (TGCT) SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies. Type: | 0 | 0 | 0 | 17 |
 | aptaTargets Pioneering therapies based on aptamer technology aptaTargets is a clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants and immunomodulators being developed from preclinical stages up to clinical proof-of-concept. Biopharmaceutical, Biotechnology, Aptamers, Immunology, Stroke, and Inflammatory diseases Type: | 1 | 0 | 1 | 11 |
 | Kyomei Animal Identical, Plant Grown Kyomei is a molecular farming and biotechnology start-up that focuses on the production of animal-identical proteins, pigments, ingredients and molecules using the power of plants, photosynthesis, and molecular biology. We aim to fundamentally transform agriculture and the food industry by decoupling the deleterious impact of animal agriculture from its byproducts and offering a more compelling, lower cost and sustainable means of production. Animal-identical benefits. Plant-grown production. Agtech, Bioengineering, Molecular Farming, Alternative Protein, Ingredients, Innovation, Biotechnology, Foodtech, Plant-based, Plant Molecular Farming, Genetic Editing, CRISPR, Downstream Processing, Plant Transformation, Protein, Protein Extraction, and Leaf Protein Type: | 0 | 0 | 0 | 9 |
 | Inoviv Accelerating the Development of New Medicines with Targeted Proteomics Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development. Proteomics, Biomarker Discovery, Translational Biomarkers, Mass Spectrometry, Targeted Proteomics, Discovery Proteomics, Biomarkers, Precision Medicine, Proteomic Analysis, Proteome Profiling , Quantitative Proteomics, Liquid Chromatography Mass-Spectrometry (LC-MS), Post-Translational Modifications (PTMs), Quantitative Biomarkers, Clinical Proteomics, Immuno-Precipitation Mass Spectrometry (IP-MS), Proteins, LC-MS Proteomics, Proteomics Services, and Protein Identification Type: | 0 | 0 | 0 | 34 |
 | STALICLA Bringing Precision Medicine to patients with Neurodevelopmental Disorders, including Autism Spectrum Disorder STALICLA SA is a Swiss clinical-stage biopharmaceutical company pioneering Neuro Precision Medicine in neurodevelopmental and neuropsychiatric disorders. With state-of-the-art technology platforms and clinical trials for Autism Spectrum Disorder (ASD) and Substance Use Disorder (SUD), STALICLA is changing the landscape of brain disease treatments. Neurodevelopmental Disorders: To propel neurodevelopmental research, STALICLA have identified patient subgroups and their matching candidate drugs within Autism Spectrum Disorder using its trailblazing, multi-omics DEPI platform. STALICLA is currently preparing Phase 2 trials for STP1, STALICLA's first patient subgroup-matched precision treatment. Substance Use Disorder research: … Type: | 0 | 0 | 0 | 28 |
 | Procavea Biotech Procavea Biotech is on a mission to solve the problem of delivering RNA-based drugs to non-liver tissues. At Procavea we're developing nonviral protein cages as carriers for the delivery of RNA Therapeutics to specific tissues in the body. Protein Engineering and RNA Delivery Type: | 0 | 0 | 0 | 1 |
 | Mironid® Limited Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to access multiple therapeutic areas for exploitation. Our lead programme is in the area of rare genetic kidney disease. Type: | 1 | 0 | 1 | 17 |
 | Mysthera Therapeutics Multilineage immune modulation. The next chapter in autoimmune diseases. Mysthera is a preclinical stage biotech start-up focused on developing first-in class, oral therapeutics to treat major unmet needs in autoimmune diseases. Our unique approach has potential to transform patient lives in a number of disease settings including glomerulonephritis, rheumatoid arthritis and inflammatory bowel disease. We are first to develop PIM kinase inhibitors as therapeutics for multi-lineage immune cell driven autoimmune diseases. The team are experts in PIM kinase and immunology. Mysthera was founded by Forty51 Ventures in Europe’s pharma/biotech hub, Basel, in Switzerland in early 2023. biotech, kinase inhibitors, autoimmune … Type: | 0 | 0 | 0 | 3 |
 | Mallia Therapeutics Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss Type: | 1 | 0 | 1 | 3 |
 | NK:IO Cancer treatment reimagined. Unlocking the potential of human Natural Killer cells. Type: | 0 | 0 | 0 | 13 |
 | Adamas Biotech Srl Advancing the state-of-the-art in nature-based healthcare solutions Adamas Biotech is a clinical stage company pioneering the development of nutraceutical-based prophylactic and therapeutic solutions for a range of clinical and wellness indications. The company is specialized in the development of bioactive molecules derived from botanicals, in particular, green tea catechins. Its initial pipeline is based on 100% natural formulations of green tea purified compounds, which are under development for use in cancer prevention, anti-aging, wound care and sports medicine. Type: | 0 | 0 | 0 | N/A |
 | Amara Therapeutics Revolutionising Pelvic Health Amara Therapeutics is a digital therapeutics company that develops innovative digital health solutions for patients suffering from pelvic health conditions. Type: | 0 | 0 | 0 | 8 |
 | Adaptyv Bio Next-generation protein engineering Proteins are the most advanced nanotechnology we know of. At Adaptyv Bio we’re building a next-gen protein foundry to allow you to synthesize and test any protein you design. Type: | 0 | 0 | 0 | 16 |
 | CaSRevolution A new hope for patients affected by Alzheimer’s disease CaSRevolution is a research company specialized in devising innovative therapies for neurodegeneration diseases We have discovered a new mechanism that explains the progression of Alzheimer’s Disease and identified a potential therapeutic approach biotech, neurodegeneration, startup, and alzheimer Type: | 0 | 0 | 0 | 5 |
 | Delta Life Science We make rapid, highly sensitive and low-cost biosensing accessible for everyone. Enabling more. For less. It's our mission to make label-free, multiplexed biosensing accessible to all. Assay Developers need to validate next-gen biomarker panels for more accurate diagnostics. Academic Researchers need to extract more data from precious samples to guide their studies. Pharma Scientists need to speed up drug development by collecting extensive data from a wide range of samples. The Merits Of Label-Free Biosensing? Label-free biosensing enables real-time, direct detection without the need for tagging target molecules. This revolutionary approach benefits a wide range of applications, from studying molecular … Type: | 0 | 0 | 0 | 38 |
 | pHion Therapeutics Developing Next Generation mRNA Vaccines pHion Therapeutics is a UK based biotech delivering ground-breaking nucleic acid vaccines and therapeutics. The proprietary RALA peptide-based drug delivery system is based on a sequence of 30 amino acids which condenses anionic cargo (RNA and DNA), irrespective of size, into nanoparticles. These nanoparticles are highly efficient at cellular entry with 100% release from the endosomes. When used in vaccines, the RALA platform can deliver multiple anionic molecules, such as mRNA, in a stealth-like way by evading detection. This generates both a potent antigen-specific CD8+ T-cell response that is ideal for therapeutic vaccines, and a … Type: | 0 | 0 | 0 | 12 |
 | Tharimmune, Inc. Biotech company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. Tharimmune, Inc. (Nasdaq: THAR) is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or "uncontrollable itching" in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting unique epitopes with novel mechanisms of action against well-known, validated targets in multiple solid tumors. Tharimmune has a license agreement with OmniAb, … Type: | 0 | 0 | 0 | 6 |
 | VisusNano Ltd VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for YAG laser capsulotomy after surgery, our device has the potential to revolutionise cataract surgery in both the human and veterinary markets. Type: | 0 | 0 | 0 | 5 |
 | GeneHub Empowering patients to bridge rare disease research and trials through a revolutionary clinico-genomic databank. Backed by VCs and an IUK government grant, GeneHub is building the world's first patient-controlled, clinico-genomic databank to bridge rare disease research and clinical trials. GeneHub enhances patient visibility and engagement by elevating patients into verified, zero-party data partners equipped with longitudinal real-world data from primary and secondary care. To ensure privacy, patients must consent to researchers analysing their anonymised clinico-genomic data in secure, on-demand, clean rooms. Patients actively engaging with researchers benefit from free advanced diagnostics such as DNA and mRNA sequencing, accelerating clinical trial … Type: | 0 | 0 | 0 | 8 |
 | Napo Therapeutics We cultivate reciprocal relationships with anyone who crosses our path We are Napo Therapeutics: an European pharmaceutical company, a young start-up led by a team of experienced professionals. Our mission is to improve the quality of life of people suffering from rare diseases and pathologies with a strong unmet medical need through innovative solutions. Our name reflects our story: The Napo River crosses the territories of the Amazon where the Croton lechleri tree grows – the plant from which we extract the sap that contains a precious active ingredient. We are investigating an innovative and first-in-class drug thanks to the … Type: | 0 | 0 | 0 | 8 |
 | Orexa B.V. Developing a medicine that increases food intake Orexa is a phase 2 pharmaceutical company that develops and commercializes therapeutics to increase food intake. Its lead compound ORE-001 is a proprietary oral formulation, based on a well known anesthetic. The company has started its first phase 2a study in the Prevention of Post-Operative Ileus. Furthermore it is in preparation for phase 2a studies in Anorexia and Cachexia. With these three indications increased food intake could lead to an improved patient health, a shorter hospital stay and significant cost savings. Orexa was founded in 2016 and is headquartered in Herpen (Oss Region, … Type: | 0 | 0 | 0 | 1 |
 | ACTIMED THERAPEUTICS Innovation in Cachexia ACTIMED THERAPEUTICS LTD is a company based out of the United Kingdom. Type: | 0 | 0 | 0 | 14 |
 | FindMeCure Bringing research closer to patients Whether we help patients find treatments in research through FindMeCure's search platform or we help the industry plan successful clinical trials through TrialHub, we have one mission: Bringing Research Closer to Patients. FindMeCure's clinical trial search engine is used on a daily basis by people searching for clinical trials and so far we have served close to a million people worldwide. One of the things we learned along the way is that today's study planning process is often inefficient and causes unmet patient needs resulting in unmet recruitment targets and higher budgets. To address this … Type: | 0 | 0 | 0 | 28 |
 | MPC Therapeutics Biotech company focused on cellular rejuvenation to fight cancer & degenerative pathologies. At MPC Therapeutics, we are convinced that mitochondria, the small organelles at the core of the cell's metabolism, represent untapped therapeutic targets. Headquartered in Switzerland, our startup is focused on cellular rejuvenation to improve the performance of cell therapies and treat degenerative pathologies. Our novel approach uses proprietary first-in-class small molecules that specifically target mitochondria to trigger metabolic reprogramming. Visit our website for more info. Longevity, Mitochondria, Cellular rejuvenation, Immunotherapy, and CAR T cell therapy Type: | 0 | 0 | 0 | 6 |
 | Ukko On a mission to solve food allergies and sensitivities Ukko is improving the lives of millions that suffer from food allergies and disorders. We are using cutting edge technologies in immunology, computational biology, and plant science to develop a new approach. We have offices in Tel Aviv, Israel and Palo Alto, California. Type: | 0 | 0 | 0 | 60 |
 | Automated Engineering Services, Inc. Solutions for Better Biotech AES (Automated Engineering Services, Inc.) was formed after recognizing gaps with most system vendors and integrators who lack a strong background in Life Science, particularly with manufacturing operations in mind. In addition to services provided, AES also manufactures their own line of rockers, pump towers and 2-15L bioreactor systems. AES is made up of world class engineers and business experts from diverse backgrounds including operations, automation consulting, DCS/PLC programming, start-up, commissioning, validation and manufacturing. In addition to our professional engineering capabilities, AES has added a top-tier business development/sales-marketing team to the organization to continue to grow … Type: | 0 | 0 | 0 | 177 |
 | Zero Carb Company On top of your carbs. Zero Carb Company’s objective is to accommodate a structural and meaningful change in worldwide consumers’ everyday food consumption pattern. We are developing a range of zero carb bakery products, with and without gluten. Low in sugar and carbs, high in proteins and super tasty. Our innovations will permanently change the world-in-food, and help consumers who want to or have got to be on top of their carbs. Zero Carb Company is an ambitious joint venture between Bakker Wiltink, a state of the art, third generation bakery and TOP BV, an innovative developer for the food … Type: | 0 | 0 | 0 | 4 |
 | BlueNalu Cell-cultured seafood company, satisfying the global appetite for seafood in a fresh, sustainable and humane way. BlueNalu's mission is to be the global leader in cell-cultured seafood, providing consumers with great tasting, healthy, safe and trusted seafood products, that support the sustainability and diversity of our ocean. Consumers worldwide have become increasingly aware of the challenges that exist in our fishing and seafood industry. BlueNalu will disrupt the current industry practice, in which fish are farmed or wild-caught in our oceans and seas. Instead, we will produce real seafood products directly from fish cells, in a way that is healthy … Type: | 8 | 2 | 4 | 57 |
Startup